Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

per Thum, Thomas, Springer, Jochen
Publicat 2011

Evidence for an effect of ACE inhibitors on cancer cachexia

per Schanze, Nancy, Springer, Jochen
Publicat 2012

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancie...

per Tschirner, Anika, Springer, Jochen
Publicat 2012

MicroRNAs in muscle wasting

per Suzuki, Tsuyoshi, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2019)

Biomarkers for cancer cachexia: where do we stand?

per Palus, Sandra, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2020)

Physical activity for the prevention and treatment of sarcopenic obesity

per Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2017)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?

per Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?

per Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass

per Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2017)

Skeletal muscle wasting in chronic heart failure

per Suzuki, Tsuyoshi, Palus, Sandra, Springer, Jochen
Publicat a ESC Heart Fail (2018)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

per Lena, Alessia, Anker, Markus S., Springer, Jochen
Publicat a Int J Mol Sci (2020)

Muscle wasting: an overview of recent developments in basic research

per Palus, Sandra, von Haehling, Stephan, Springer, Jochen
Publicat 2014

Blocking myostatin: muscle mass equals muscle strength?

per Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2020)

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

per Drescher, Cathleen, Konishi, Masaaki, Ebner, Nicole, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2015)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in...

per Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2015)

Concern regarding quality and quality of muscle

per Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia

per Konishi, Masaaki, Ishida, Junichi, Saito, Masakazu, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients

per Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients

per Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle

per Konishi, Masaaki, Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Publicat a J Cachexia Sarcopenia Muscle (2016)